COVID-19 Variant Supplement – Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV Woodside, Michael T | University of Alberta | Operating Grant | $50,000 CIHR Alberta 2021 Read More
COVID-19 Variant Supplement – Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase James, Michael N | University of Alberta | Operating Grant | $50,000 CIHR Alberta 2021 Read More
COVID-19 Variant Network – Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses Houghton, Michael | University of Alberta | Operating Grant | $100,000 CIHR Alberta 2021 Read More
